FDA draft guidance on compounding and repackaging

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2015年 / 1540卷 / 1期
关键词：
D O I：
10.1007/s40278-015-7850-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [31] Adverse reactions with HCT/Ps: FDA issues draft guidance
    Reactions Weekly, 2015, 1541 (1) : 1 - 1
  • [32] Some statistical considerations on the FDA draft guidance for individual bioequivalence
    Hsuan, FC
    STATISTICS IN MEDICINE, 2000, 19 (20) : 2879 - 2884
  • [33] Repackaging Cigarettes - Will the Courts Thwart the FDA?
    Bayer, Ronald
    Gostin, Lawrence
    Marcus-Toll, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22): : 2065 - 2067
  • [34] FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology
    Russell, Elizabeth S.
    Aubrun, Elodie
    Moga, Daniela C.
    Guedes, Sandra
    Camelo Castillo, Wendy
    Hardy, Janet R.
    Cole, J. Alexander
    Jagun, Oladayo
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 7 (01)
  • [35] FDA releases tissue-agnostic cancer drug draft guidance
    Asher Mullard
    Nature Reviews Drug Discovery, 2022, 21 : 868 - 868
  • [36] FDA issues draft guidance on development of abuse-deterrent opioids
    Reactions Weekly, 2013, 1435 (1) : 4 - 4
  • [37] FDA releases tissue-agnostic cancer drug draft guidance
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (12) : 868 - 868
  • [38] FDA draft guidance on benefit-risk assessments for NDAs and BLAs
    Reactions Weekly, 2021, 1876 (1) : 1 - 1
  • [39] Analytical procedures and method validation: Highlights of the FDA's draft guidance
    Brown, R
    Caphart, M
    Faustino, P
    Frankewich, R
    Gibbs, J
    Leutzinger, E
    Lunn, G
    Ng, L
    Rajagopalan, R
    Chiu, Y
    Sheinin, E
    LC GC NORTH AMERICA, 2001, 19 (01) : 74 - +
  • [40] FDA's final and draft nanotechnology guidance documents: No big surprises
    Nanotechnol. Law Bus., 1 (54-58):
12345